Dr John Riches

Dr John Riches

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

Dr. John Riches is a Clinical Reader at Barts Cancer Institute and Honorary Consultant Haemato-oncologist at Barts Health NHS Trust in London. He undertook his undergraduate degree in medical sciences at the University of Cambridge before qualifying from Oxford University Medical School in 2003. He subsequently trained in haematology on the Imperial College training rotation based at Hammersmith hospital. He developed his research interest during his CRUK Clinical Research Fellowship with Professor Gribben at Barts Cancer Institute where he studied the defects underlying impaired T-cell immunity in chronic lymphocytic leukaemia (CLL) focusing on the impact of lenalidomide, being awarded a PhD in 2013. He stayed in this laboratory for a period of post-doctoral work investigating the expression and function of integrins on CLL cells. He was awarded the Hamblin prize by the UK CLL forum in 2015 for his work documenting the particular differences associated with the presence of trisomy 12. In 2016 he joined the Centre for Haemato-Oncology at Barts Cancer Institute as a Clinical Senior Lecturer funded by a fellowship from the Wellcome Trust. He leads the cancer immunometabolism research group which focuses on investigating the alterations in metabolism that accompany B-cell activation and how this is reflected in the metabolism of low- and high-grade lymphomas. In addition he remains clinically active at Barts where he is the principal investigator on several clinical trials.

Updated 28 November 2023